Ami Fadia
Stock Analyst at Needham
(2.29)
# 2,490
Out of 4,832 analysts
410
Total ratings
37.47%
Success rate
-1.75%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NMRA Neumora Therapeutics | Reiterates: Buy | $5 | $0.64 | +676.40% | 9 | May 13, 2025 | |
| RVMD Revolution Medicines | Reiterates: Buy | $57 | $39.92 | +42.79% | 23 | May 8, 2025 | |
| AVDL Avadel Pharmaceuticals | Reiterates: Buy | $19 | $8.70 | +118.39% | 36 | May 8, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $30 → $27 | $6.13 | +340.46% | 20 | May 7, 2025 | |
| JAZZ Jazz Pharmaceuticals | Reiterates: Buy | $200 | $105.62 | +89.37% | 30 | May 7, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $49 | $34.08 | +43.78% | 37 | May 7, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $138 → $139 | $119.36 | +16.45% | 14 | May 6, 2025 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $80 | $36.03 | +122.04% | 11 | May 5, 2025 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $29 | $8.03 | +261.37% | 20 | May 2, 2025 | |
| BIIB Biogen | Reiterates: Hold | n/a | $120.47 | - | 40 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.50 | - | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $133 → $130 | $98.80 | +31.58% | 30 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.27 | +844.88% | 15 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $83 | $40.62 | +104.33% | 27 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $17.39 | +61.01% | 8 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $153 | $103.51 | +47.81% | 14 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $4.82 | - | 22 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $10.11 | +3,066.75% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $23.82 | +214.93% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.92 | +2,359.02% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $26.03 | +142.07% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $5 | $2.33 | +114.91% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $16.91 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.79 | +1,132.49% | 4 | Jan 3, 2018 |
Neumora Therapeutics
May 13, 2025
Reiterates: Buy
Price Target: $5
Current: $0.64
Upside: +676.40%
Revolution Medicines
May 8, 2025
Reiterates: Buy
Price Target: $57
Current: $39.92
Upside: +42.79%
Avadel Pharmaceuticals
May 8, 2025
Reiterates: Buy
Price Target: $19
Current: $8.70
Upside: +118.39%
Day One Biopharmaceuticals
May 7, 2025
Maintains: Buy
Price Target: $30 → $27
Current: $6.13
Upside: +340.46%
Jazz Pharmaceuticals
May 7, 2025
Reiterates: Buy
Price Target: $200
Current: $105.62
Upside: +89.37%
Harmony Biosciences Holdings
May 7, 2025
Reiterates: Buy
Price Target: $49
Current: $34.08
Upside: +43.78%
Neurocrine Biosciences
May 6, 2025
Maintains: Buy
Price Target: $138 → $139
Current: $119.36
Upside: +16.45%
Praxis Precision Medicines
May 5, 2025
Reiterates: Buy
Price Target: $80
Current: $36.03
Upside: +122.04%
Bicycle Therapeutics
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $8.03
Upside: +261.37%
Biogen
May 2, 2025
Reiterates: Hold
Price Target: n/a
Current: $120.47
Upside: -
Apr 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.50
Upside: -
Apr 28, 2025
Maintains: Buy
Price Target: $133 → $130
Current: $98.80
Upside: +31.58%
Apr 10, 2025
Reiterates: Buy
Price Target: $12
Current: $1.27
Upside: +844.88%
Apr 9, 2025
Reiterates: Buy
Price Target: $83
Current: $40.62
Upside: +104.33%
Apr 8, 2025
Reiterates: Buy
Price Target: $28
Current: $17.39
Upside: +61.01%
Apr 1, 2025
Reiterates: Buy
Price Target: $153
Current: $103.51
Upside: +47.81%
Feb 26, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.82
Upside: -
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $10.11
Upside: +3,066.75%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $23.82
Upside: +214.93%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.92
Upside: +2,359.02%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $26.03
Upside: +142.07%
Jan 30, 2019
Downgrades: Market Perform
Price Target: $12 → $5
Current: $2.33
Upside: +114.91%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $16.91
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.79
Upside: +1,132.49%